Shouyao Holdings (Beijing) Co. Ltd. A Market Cap ($750.15 Million)
Market Cap & Net Worth: Shouyao Holdings (Beijing) Co. Ltd. A (688197)
Shouyao Holdings (Beijing) Co. Ltd. A market cap. Shouyao Holdings (Beijing) Co. Ltd. A (SHG:688197) has a market capitalization of $750.15 Million (CN¥5.13 Billion) as of November 8, 2026. Listed on the SHG stock exchange, this China-based company holds position #9867 globally and #2555 in its home market, demonstrating a 5.12% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shouyao Holdings (Beijing) Co. Ltd. A's stock price CN¥34.47 by its total outstanding shares 148719343 (148.72 Million). Also see Shouyao Holdings (Beijing) Co. Ltd. A (688197) cash conversion ratio for how efficiently the company converts equity into cash flow.
Shouyao Holdings (Beijing) Co. Ltd. A Market Cap History (2022–2026)
Shouyao Holdings (Beijing) Co. Ltd. A market cap history from 2022 to 2026. Data shows growth from $528.39 Million to $750.15 Million (1.54% CAGR). Check 688197 share price today for real-time trading data and today's change.
Shouyao Holdings (Beijing) Co. Ltd. A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shouyao Holdings (Beijing) Co. Ltd. A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Shouyao Holdings (Beijing) Co. Ltd. A equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
87.22x
Shouyao Holdings (Beijing) Co. Ltd. A's market cap is 87.22 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $528.39 Million | $1.83 Million | -$173.82 Million | 289.18x | N/A |
| 2023 | $1.20 Billion | $5.23 Million | -$185.57 Million | 229.69x | N/A |
| 2024 | $649.39 Million | $3.94 Million | -$211.94 Million | 164.73x | N/A |
| 2025 | $756.02 Million | $8.67 Million | -$128.83 Million | 87.22x | N/A |
Competitor Companies of 688197 by Market Capitalization
Companies near Shouyao Holdings (Beijing) Co. Ltd. A in the global market cap rankings as of November 8, 2026. Also see Shouyao Holdings (Beijing) Co. Ltd. A assets under control for a full breakdown of the balance sheet.
Key companies related to Shouyao Holdings (Beijing) Co. Ltd. A by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Shouyao Holdings (Beijing) Co. Ltd. A (2022–2026)
Market capitalization of Shouyao Holdings (Beijing) Co. Ltd. A from 2022 to today. Between 2022 and today, Shouyao Holdings (Beijing) Co. Ltd. A's market cap moved from $528.39 Million to $ 750.15 Million, with a yearly change of 1.54%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥750.15 Million | -0.78% |
| 2025 | CN¥756.02 Million | +16.42% |
| 2024 | CN¥649.39 Million | -45.93% |
| 2023 | CN¥1.20 Billion | +127.31% |
| 2022 | CN¥528.39 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 8th, 2026 the market cap of Shouyao Holdings (Beijing) Co. Ltd. A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $750.15 Million USD |
| MoneyControl | $750.15 Million USD |
| MarketWatch | $750.15 Million USD |
| marketcap.company | $750.15 Million USD |
| Reuters | $750.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shouyao Holdings (Beijing) Co. Ltd. A
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.